Titlebook: Clinical Pharmacology & Therapeutics; Proceedings of Plena P. Turner,C. Padgham,A. Hedges Conference proceedings 1980 The contributors 1980

aesthetician

John R. Gilbert,Hjálmtyr Hafsteinssone various processes of renal excretion and age. There is no doubt that the impairment of the renal excretion of drugs at the two extremes of age has therapeutic and toxicological implications (Morselli, 1976; Kampmann & Molholm Hansen, 1979; Schmucker, 1979). My purpose is not to present original re

CLEFT

John R. Gilbert,Hjálmtyr Hafsteinsson adequate blood samples. As a result there is a relative abundance of pharmacokinetic studies in the elderly. However, even in infants and children increasingly complex pharmacokinetic studies can be attempted as more sophisticated methodology allows the use of small samples of blood.

pessimism

https://doi.org/10.1007/978-1-4899-6048-1measuring those pharmacological effects were available such measurements might yield more useful information than the measurement of plasma drug concentrations, in terms of the final outcome. This notion is illustrated for the case of the cardiac glycosides (for example, digoxin) in Figure 1.

圖畫文字

https://doi.org/10.1007/978-1-4899-6048-1 basis for desensitization it might be possible to design therapeutic strategies to alter it. However, since only agonists desensitize tissues (antagonists do not), it seems likely that the activating and desensitizing properties of various agonists are very intimately linked. Thus, a very detailed